Get the Stockscreener App
0.99
6.45%
0.06
Iridex Corp stock is traded at $0.99, with a volume of 67,562.
It is up +6.45% in the last 24 hours and up +1.73% over the past month.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$0.93
Open:
$0.92
24h Volume:
67,562
Relative Volume:
0.72
Market Cap:
$15.87M
Revenue:
$48.43M
Net Income/Loss:
$-11.04M
P/E Ratio:
-1.4776
EPS:
-0.67
Net Cash Flow:
$-7.00M
1W Performance:
+12.26%
1M Performance:
+1.73%
6M Performance:
-45.00%
1Y Performance:
-52.17%
1-Day Range:
$0.92
$0.995
1-Week Range:
$0.88
$0.995
52-Week Range:
$0.782
$2.408
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
0.99 | 15.87M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
133.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.75 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.84 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.82 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.92 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
Iridex corp director William Moore acquires $19,372 in stock By Investing.com - Investing.com South Africa
Iridex corp director William Moore acquires $19,372 in stock - Investing.com
Iridex corp CEO Patrick Mercer buys $240 in common stock By Investing.com - Investing.com Canada
Iridex corp CEO Patrick Mercer buys $240 in common stock - Investing.com Australia
IRIDEX expands stock plan and amends charter - Investing.com
IRIDEX expands stock plan and amends charter By Investing.com - Investing.com UK
Iridex director William Moore buys $29,121 in stock By Investing.com - Investing.com South Africa
Iridex director William Moore buys $29,121 in stock - Investing.com
Iridex corp CFO Romeo Dizon acquires shares worth $197 By Investing.com - Investing.com Nigeria
Iridex corp CFO Romeo Dizon acquires shares worth $197 - Investing.com
IRIDEX amends agreement with Novel Inspiration International - Investing.com
IRIDEX amends agreement with Novel Inspiration International By Investing.com - Investing.com India
IRIDEX Faces Nasdaq Delisting Over Equity Shortfall - Investing.com
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
IRIDEX Corporation (NASDAQ:IRIX) Q1 2025 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Investments ... - Yahoo
IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Gro - GuruFocus
Iridex: Q1 Earnings Snapshot - The Washington Post
IRIDEX earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
IRIDEX earnings matched, revenue fell short of estimates - Investing.com
IRIDEX Corp Reports Q1 2025 Earnings: EPS of -$0.10 Beats Estima - GuruFocus
Iridex Reports First Quarter 2025 Financial Results - Yahoo Finance
Head to Head Survey: Xcorporeal (OTCMKTS:XCRP) versus IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX Changes Course (NASDAQ:IRIX) - Seeking Alpha
Iridex corp director William Moore buys $24,143 in common stock By Investing.com - Investing.com Canada
Iridex corp director William Moore buys $24,143 in common stock - Investing.com
IRIDEX Corp Director William M. Moore Acquires 20,000 Shares - TradingView
Glaucoma Treatment Pioneer Iridex Announces Q1 2025 Financial Results DateKey Details for Investors - Stock Titan
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 - Yahoo Finance
IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Call Transcript - MSN
IRIDEX Corp Board Reshuffles Following Novel Transaction - Investing.com Australia
Iridex to Host Strategic Vision Call on April 16, 2025 - Yahoo Finance
IRIDEX Corp Board Reshuffles Following Novel Transaction By Investing.com - Investing.com South Africa
IRIDEX Director Resigns to Comply with Rights Agreement - Investing.com
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Iridex Corp Stock (IRIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mercer Patrick | President and CEO |
Jun 13 '25 |
Buy |
0.96 |
250 |
240 |
386,730 |
| MOORE WILLIAM M | Director |
Jun 12 '25 |
Buy |
0.97 |
20,000 |
19,494 |
168,650 |
| MOORE WILLIAM M | Director |
Jun 11 '25 |
Buy |
0.96 |
10,000 |
9,627 |
148,650 |
| Dizon Romeo R | Chief Financial Officer |
Jun 11 '25 |
Buy |
0.96 |
245 |
236 |
15,245 |
| Dizon Romeo R | Chief Financial Officer |
Jun 09 '25 |
Buy |
0.99 |
500 |
495 |
14,665 |
| Dizon Romeo R | Chief Financial Officer |
Jun 10 '25 |
Buy |
0.98 |
335 |
327 |
15,000 |
| Dizon Romeo R | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.97 |
1,500 |
1,455 |
14,165 |
| Dizon Romeo R | Chief Financial Officer |
Jun 02 '25 |
Buy |
1.00 |
100 |
100 |
12,565 |
| Dizon Romeo R | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.99 |
100 |
99 |
12,665 |
| Dizon Romeo R | Chief Financial Officer |
May 29 '25 |
Buy |
0.98 |
200 |
197 |
12,465 |
0.63%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):